Renin Angiotensin-Aldosterone System Inhibitor (RAASi)
Showing 1 - 25 of >10,000
Hyperkalaemia and Its Impact on Therapy With RAASi
Recruiting
- Hyperkalaemia
- +2 more
-
Portsmouth, United KingdomPortsmouth Hospitals University NHS Trust
Nov 10, 2022
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo
Recruiting
- PreDiabetes
- +3 more
- Sacubitril-Valsartan Tab 97-103 MG
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jul 21, 2022
Obesity, Cardiovascular Diseases, Hypertension Trial in Birmingham (Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80
Recruiting
- Obesity
- +5 more
- Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
- Valsartan 80 mg Oral Tablet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 6, 2022
Immunoglobulin A Nephropathy Trial in Denver (Sparsentan)
Not yet recruiting
- Immunoglobulin A Nephropathy
-
Denver, ColoradoTravere Investigational Site
May 12, 2023
Heart Rate Variability on Endothelial Function Via RAAS
Not yet recruiting
- Obstructive Sleep Apnea
-
Kuching, Sarawak, MalaysiaUniversiti Malaysia Sarawak
Jan 30, 2022
Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system
Not yet recruiting
- Nephropathy
- +2 more
- Huaier granule
- +2 more
- (no location specified)
Apr 20, 2023
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
Recruiting
- Heart Failure
- Mortality
- Angiotensin receptor neprilysin inhibitor (ARNI)
- Renin-Angiotensin System Inhibitor (RAS inhibitor)
-
Wonju, Gangwondo, Korea, Republic ofYonsei University Wonju College of Medicine
Dec 20, 2022
Metabolic Syndrome Trial in Nashville (Low Salt diet plus Placebo tablet, Low Sodium diet plus Salt tablet, Epleronone)
Completed
- Metabolic Syndrome
- Low Salt diet plus Placebo tablet
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 30, 2020
Hypertension Trial in London (Preoperative ACEi/ARB management)
Completed
- Hypertension
- Preoperative ACEi/ARB management
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 21, 2021
Hypertension Trial in Boston (Lisinopril, Atenolol)
Withdrawn
- Hypertension
- Lisinopril, Atenolol
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 7, 2021
Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,
Completed
- Idiopathic Membranous Nephropathy
- symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
- experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
-
Paris, FranceDepartment of Nephrology , Tenon hospital - APHP
Oct 18, 2021
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin
Not yet recruiting
- Hyperkalemia
- No intervention
- (no location specified)
Aug 10, 2020
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
Recruiting
- Hyperkalemia
-
La Jolla, California
- +105 more
Jan 19, 2023
Hyperkalemia, Renal Insufficiency, Chronic Trial in China (Patiromer Powder for Oral Suspension (Part A), Placebo (Part B),
Recruiting
- Hyperkalemia
- Renal Insufficiency, Chronic
- Patiromer Powder for Oral Suspension (Part A)
- +2 more
-
Hefei, Anhui, China
- +21 more
Sep 15, 2022
Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)
Recruiting
- Chronic Kidney Diseases
- +4 more
- Lokelma Oral Product
-
London, United KingdomSt Georges, University of London
Feb 16, 2022
Chronic Kidney Diseases Trial in Pittsburgh (Intervention Arm, Usual Care)
Enrolling by invitation
- Chronic Kidney Diseases
- Intervention Arm
- Usual Care
-
Pittsburgh, PennsylvaniaUPMC Presbyterian
Jan 4, 2023
Human Intestinal Amino Acid Absorption and Role ofLocal RAS
Completed
- Renin-Angiotensin Aldosterone System (RAS)
- biopsy of intestinal tissue
- +2 more
-
Basel, Switzerland
- +1 more
Aug 19, 2020
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Recruiting
- Hypertension
- +17 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 3, 2023
Immune Checkpoint Inhibitor in NSCLC Patients
Not yet recruiting
- Adverse Reactions
- +3 more
- renin-angiotensin system inhibitors or angiotensin-receptor-neprilysin inhibitor
- (no location specified)
Jul 15, 2020